通过集成式策略识别的α2A上腺素受体的新型支架激素
Shiyang Sun1, Pengyun Li1, Jiaqi Wang2
1National Engineering Research Center for Strategic Drugs, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
新型化合物SY-15和SY-17被确定为潜在的α-2A上腺素受体 (α2A-AR) 激动剂. 这些化合物表现出双位结合,为开发具有提高选择性的镇静剂和止痛药提供了新的策略.
科学领域:
- 药理学和药物化学 药理学和药物化学
- 计算机化药物发现技术
背景情况:
- 阿尔法-2A上腺素受体 (α2A-AR) 是镇静剂和止痛药的关键标.
- 现有的具有意达环的α2A-AR配体由于与意达和其他受体的相互作用,导致异于目标效应.
- 需要新的α2A-AR配体,具有更好的选择性和减少副作用.
研究的目的:
- 通过基于合体的连接物发现策略,识别具有独特支架的新型α2A-AR激活剂.
- 研究新发现的化合物的结合相互作用和潜在的治疗应用.
主要方法:
- 集团式虚拟查与长期分子动力学 (MD) 模拟集成.
- 使用蛋白激酶A (PKA) 再分配试验进行初步生物评估.
- 测量细胞内循环腺单酸盐 (cAMP) 的水平.
- 使用MD模拟,对绑定模式和自由能量的计算分析.
主要成果:
- 化合物SY-15和SY-17在PKA试验中表现出显著的生物活性,并且剂量取决于细胞内cAMP水平的降低.
- 在100μM时,SY-15和SY-17分别降低了cAMP水平63.43%和53.83%.
- 医学模拟显示,SY-15和SY-17充当比托皮激动剂,同时结合于orthosteric位点和新型外位点.
- 对SY-15和SY-17的计算结合自由能量分别为-45.93和-71.97 kcal/mol.
结论:
- 综合计算和实验方法成功识别了新型α2A-AR激动剂SY-15和SY-17.
- 这些化合物的双位点占用提供了一种有前途的策略,以增强连接体亲和力和选择性.
- 这些发现为下一代镇静剂和止痛药的合理设计提供了新的方向.
更多相关视频
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
09:09Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
Published on: September 20, 2016
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
